One fact, nevertheless, remains the same: cardiovascular disease (CVD) is the main cause of death in the European Union, killing over 2 million people per year. CVD costs the EU economy over 192 billion Euros annually. Many of these deaths could be averted with proper prevention policies.
These new statistics will be the main focus of the meeting of the Members of the European Parliament Heart Group which will take place in Brussels today, 26 February 2008.
“These latest figures show that cardiovascular disease is a critical health problem for Europe and must be taken seriously. High risk countries should take urgent steps to implement measures to reduce the burden of CVD. The elevated mortality rates in some European countries are also unacceptable from both a human and economical point of view” declared Dr Andrejevs co-chair of the MEP Heart Group.
Aware of this critical health problem, members of the European Parliament voted with an overwhelming majority a Resolution on action to tackle cardiovascular disease on 12 July 2007. Last October, the MEP Heart Group was officially created. The group works together with the European Heart Network3and the European Society of Cardiology4 to gather and exchange information on cardiovascular health and to stimulate initiatives across Europe on cardiovascular disease prevention.
EHN statistics show that CVD costs European economy 192 billion Euros a year, which results in a per capita cost of 391 Euros. 57% of this is directly linked to health care, 21% to productivity losses and 22 % to the cost of informal care provided by relatives and friends. “Premature death and suffering from CVD is largely avoidable, declared Ms Susanne Logstrup from the European Heart Network. These recent studies show how many western European countries have managed to reduce mortality linked to CVD. It is the duty of the EU to extend these successful policies to all Member States”. As Dr William Wijns, chair of the ESC Committee for European Relations underlines: “to those who think prevention is expensive, I say ... try disease!”
Researchers found that mortality rates due to CVD were high in some Mediterranean countries such a Greece, Portugal and regions in southern Spain and Italy. They also found that many countries had changed from being high to low risk and that current classifications did not take into account the considerable regional variations. These disparities are associated with differences in diet, alcohol consumption, smoking, physical activity, the quality of medical care and environmental factors. Western European countries show a trend towards lower mortality rates linked to CVD. Finland appears to be an example of how public health interventions can make a big difference to reduce death caused by heart disease.
Several projects are already underway aiming to provide Member States with adequate tools to help reduce the burden of CVD. These include the European Heart Health Charter5; the EuroHeart Project6 and the revised European Guidelines on CVD prevention in clinical practice7¬. The challenge for Member States today is to implement all these recommendations taking into account local economic and cultural realities. Statistics have confirmed the alarming cost of not doing so.
“As a cardiologist, says Dr William Wijns of the European Society of Cardiology, I am confronted every day with the terrible consequences of heart disease. People who normally wouldn’t consider themselves as risk takers, nevertheless take daily risks by smoking or eating unhealthily. As specialists we get to see people as patients, when the damage is done. To see Members of the European Parliament actually focus on Cardiovascular health is extremely important for the ESC as they can help Europe take further action, in particular in the field of prevention, by educating populations and by providing supportive environments helping people to choose a healthy lifestyle.”1. European Heart Journal, flagship journal of the European Society of Cardiology. For full report go to: http://www.oxfordjournals.org/our_journals/eurheartj/press_releases/freepdf/ehm604.pdf
Jacqueline Partarrieu | alfa
Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
23.04.2018 | Earth Sciences
23.04.2018 | Trade Fair News
23.04.2018 | Information Technology